THE COURAGE TO FACE COVID-19 Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
The story of doctors who developed a safe and effective early treatment for COVID-19 and their battle with the Bio- Pharmaceutical Complex that suppressed it. At the beginning of 2020, Dr. Peter McCullough was a highly regarded practicing physician, program director, teacher, and clinical investigator at a major academic medical center in Dallas, Texas. When COVID-19 arrived in March, he felt a duty to find a treatment for the disease. He wasn't alone. Other doctors all over the world were also searching for a cure. They followed the longstanding principle that it's best to tackle a sickness early, before it becomes life threatening. This is the story of how Dr. McCullough and his colleagues developed an early treatment protocol of generic, repurposed drugs and supplements that has saved millions of COVID-19 patients from hospitalization and death. John Leake Peter A. McCullough, MD, MPH
Peter A. McCullough, MD, MPH, is an internist, cardiologist, and epidemiologist who has been a leader in the medical response to COVID-19. In August of 2020 he published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” in the American Journal of Medicine. This paper presented the first synthesis of sequenced multidrug treatment of ambulatory patients infected with the virus and was subsequently updated in Reviews in Cardiovascular Medicine. He has published dozens of peer-reviewed papers on the infection and has commented extensively on the medical response in The Hill, America Out Loud, ABC, Fox News, OAN, Newsmax, Victory Channel, and a multitude of independent media outlets. He has testified on several occasions in the U.S. Senate and before several State Senate and Congressional Committees.
Commentaires